FOLH1 and posterior cortical atrophy: The identification of predictive factors, in particular of PCa bone involvement at molecular imaging, could help to refine the indication for PSMA-PET in early-BCR/BCP HSPC-patients, leading to higher detection rates, more personalized treatments, and higher cost-effectiveness from a patient and health-care perspective [17].